Pharma Discussions - Clarification FYI: I asked a couple of questions of the company yesterday, to which I received answers today. Here is what I found out (some of this information is repeat in the sense that it was reported before - but it's nice to get an updated status):
QUESTION "A": In the last Webcast, the very last line in the presentation mentioned that business development, partnership and licensing discussions had "commenced." What was meant by that statement? My understanding is that such discussions have been ongoing for many years. Thus, did something happen recently that caused such discussions to re-commence or be renewed? What changed recently?
ANSWER "A": Without reading too much into the word ‘commenced’ on the final slide of the webcast presentation, it was/is meant to reflect that new discussions have commenced with new pharma. We are still in ongoing discussions with pharma whom we already have an established rapport.
QUESTION "B": Are such discussions (as mentioned in question 8) still ongoing and in active mode?
ANSWER "B": Yes ongoing/active.
(Highlighting added by me)